Humacyte Inc (NAS:HUMA)

Q1 2026 Humacyte Inc Earnings Call Transcript

May 13, 2026 / 12:00 PM GMT

Release Date Price: $1.13 (+24.18%)

Transcript 10-Q

Key Points

Positve

Humacyte Inc (HUMA) reported a significant increase in first-quarter sales of SYMVESS, reaching $0.5 million in 2026 compared to $0.1 million in 2025.
The company has made substantial new hires in senior commercial and clinical leadership positions to drive product uptake and sales growth.
Humacyte Inc (HUMA) is expanding its commercialization efforts into international markets, including a Marketing Authorization Application submitted in Israel and a purchase commitment from Saudi Arabia.
The U.S. Department of Defense has dedicated funding for the evaluation and incorporation of Humacyte's biologic vascular repair technologies, highlighting the potential military applications.
The company is on track to commence a Phase I/II trial of its coronary tissue-engineered vessel (CTEV) for coronary artery bypass grafting in the second half of 2026.

Negative

Despite the increase in sales, Humacyte Inc (HUMA) acknowledges the need for more rapid product uptake and sales growth.
The company reported a net loss of $17.6 million for the first quarter of 2026, compared to net income of $39.1 million in the same period of 2025.
Research and development expenses increased to $19.5 million in the first quarter of 2026 from $15.4 million in 2025, impacting overall financial performance.
Contract revenue from a research collaboration decreased significantly to $2,000 in the first quarter of 2026 from $0.4 million in 2025.
Humacyte Inc (HUMA) implemented a workforce restructuring, reducing headcount by 25%, which may impact employee morale and operational capacity.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HUMA.OQ - Humacyte Inc
Q1 2026 Humacyte Inc Earnings Call
May 13, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, ladies and gentlemen, and welcome to the HumaSite First Quarter 2026 Earnings Conference Call.

Currently, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session, and instructions will follow at that time.

As a reminder, this conference call is being recorded.

I'll now turn the call over to Tom Johnson with LifeSite Advisors. Please go ahead, Tom.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Before we proceed with the call, I would like to remind everyone that certain statements made during

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.